Skip to content

MGX — Metagenomi Therapeutics Inc Institutional Holders · Q2 2026

Who owns Metagenomi Therapeutics Inc (MGX)? 49 institutions reported holding $7.45M in SEC 13F filings for Q2 2026 (period ended 2026-06-30). Largest holders: Vanguard Group Inc ($1.5M), Renaissance Technologies LLC ($883,456), Catalio Capital Management, LP ($629,502).

RankInstitutionValueSharesChange
1VANGUARD GROUP INC$1.5M1.3MAdded
2RENAISSANCE TECHNOLOGIES LLC$883,456742,400Trimmed
3Catalio Capital Management, LP$629,502528,993Hold
4Peapod Lane Capital LLC$624,779525,024Added
5TWO SIGMA INVESTMENTS, LP$611,304513,701Added
6BRIDGEWAY CAPITAL MANAGEMENT, LLC$476,357400,300Added
7WELLS FARGO & COMPANY/MN$451,614379,508Added
8GEODE CAPITAL MANAGEMENT, LLC$343,672288,665Trimmed
9PURA VIDA INVESTMENTS, LLC$314,625264,391Hold
10BlackRock, Inc.$306,581257,631Added
11JACOBS LEVY EQUITY MANAGEMENT, INC$190,400160,000Trimmed
12STATE STREET CORP$142,622119,850Trimmed
13MILLENNIUM MANAGEMENT LLC$135,690114,025Trimmed
14Man Group plc$129,865109,130Added
15Resolute Advisors LLC$107,03389,944Hold
16Marquette Asset Management, LLC$85,82472,121New
17NORTHERN TRUST CORP$82,03668,938Trimmed
18RBF Capital, LLC$76,18564,021Hold
19XTX Topco Ltd$66,29155,707Added
20BBR PARTNERS, LLC$63,55053,403Hold
21JANE STREET GROUP, LLC$45,69138,396Trimmed
22Fortitude Advisory Group L.L.C.$44,25637,190Hold
23CITADEL ADVISORS LLC$21,24317,851Added
24Qube Research & Technologies Ltd$20,05216,850New
25UBS Group AG$18,79415,793Trimmed

Source: SEC Form 13F filings · as of 2026-06-30